Research Article

Synthesis and Characterization of Cobalt(III) and Copper(II) Complexes of 2-((E)-(6-Fluorobenzo[d]thiazol-2-ylimino) methyl)-4-chlorophenol: DNA Binding and Nuclease Studies—SOD and Antimicrobial Activities

Table 1

Antimicrobial activities of synthesized compounds.

Sl. numberCompounds
(30 µg/disk)
MIC (zone of inhibition ± SD) in µg/mL
E. coliP. aeruginosaB. subtilisS. aureusC. albicansA. niger

L111.0 (15 ± 0.6)12.6 (17 ± 0.3)12.3 (18 ± 0.9)11.9 (17 ± 0.1)19.6 (12 ± 0.2)19.2 (16 ± 0.4)
C14.7 (22 ± 0.7)4.8 (22 ± 0.9)4.8 (23 ± 0.6)4.6 (22 ± 0.7)11.3 (20 ± 0.4)11.5 (20 ± 0.6)
C23.02 (24 ± 0.4)3.45 (24 ± 0.5)3.31 (24 ± 0.4)3.39 (21 ± 0.9)8.84 (26 ± 0.2)8.92 (26 ± 0.5)
C34.4 (22 ± 0.6)4.6 (21 ± 0.6)4.46 (24 ± 0.6)3.91 (22 ± 0.6)10.6 (23 ± 0.6)9.37 (25 ± 0.6)
C43.73 (22 ± 0.8)3.71 (23 ± 0.8)3.13 (25 ± 0.1)3.64 (26 ± 0.8)9.16 (24 ± 0.5)9.42 (24 ± 0.4)
Ciprofloxacin3.12 (20 ± 0.6)3.12 (20 ± 0.6)3.0 (27 ± 0.6)3.12 (19 ± 0.6)--
Fluconazole----6.25 (16 ± 0.6)6.31 (17 ± 0.6)

Each value was replicated thrice.